We Deliver Patient Advocacy
Welcome! You have come to the perfect place to gain insight knowledge on various cancer medical concerns.
DubbelHelix is here to help assist you interact with various people who are dealing with cancer. Whether they be care takers, cancer advocates or real cancer survivors, this web portal is the perfect destination for anonymous discussion about questions you may have about cancer. So take a closer look — it will change your life.
Patient Stories
Cancer Resources
Biotechnology and Oncology
With breakthroughs in medicine emerging daily, it can be difficult to keep up with all important related information. DubbelHelix was created as a leading educational website providing updates on trends in cancer research with a focus on personalized medicine breakthroughs.
Multiple Myeloma
Bispecifics, CAR T, and in vivo gene therapies are reshaping the standard of care.
Non-Hodgkins Lymphoma
DLBCL is the most common aggressive subtype. The TGS biomarker (LMO2/CD137) was developed for DLBCL risk stratification.
Leukemia
AML, CML, ALL, CLL — each with distinct treatment pathways and active trial landscapes.
Breast Cancer
HER2+ and triple-negative subtypes have seen major treatment advances. BRCA1/2 testing now standard.
Brain Tumor
Glioblastoma and lower-grade gliomas. Tumor treating fields and immunotherapy are active research areas.
Sickle Cell Disease
Gene therapy is now approved (Casgevy, Lyfgenia). First curative options for patients previously limited to supportive care.
Please explore and find answers related to your questions and concerns. · DubbelHelix origin story →